Enwei Pharmaceutical Co., Ltd. (SHE:301331)
27.11
+0.14 (0.52%)
At close: Apr 30, 2026
6.86% (1Y)
| Market Cap | 2.74B |
| Revenue (ttm) | 879.60M |
| Net Income (ttm) | 48.14M |
| Shares Out | 101.08M |
| EPS (ttm) | 0.46 |
| PE Ratio | 58.48 |
| Forward PE | n/a |
| Dividend | 0.35 (1.30%) |
| Ex-Dividend Date | Jan 8, 2026 |
| Volume | 1,325,252 |
| Average Volume | 1,180,792 |
| Open | 27.10 |
| Previous Close | 26.97 |
| Day's Range | 26.67 - 27.22 |
| 52-Week Range | 24.10 - 39.66 |
| Beta | 0.65 |
| RSI | 54.11 |
| Earnings Date | Apr 27, 2026 |